Seimbille, Y., Murce, E., Spaan, E., Beekman, S., Handula, M., de Ridder, C., & Stuurman, D. (2023). O-76 - Preclinical evaluation of ePSMA-DM1: A PSMA-targeting theranostic small molecule drug conjugate. Nuclear Medicine and Biology, 126-127(Supplement), . https://doi.org/10.1016/j.nucmedbio.2023.108472
Chicago Style (17th ed.) CitationSeimbille, Yann, Erika Murce, Evelien Spaan, Savanne Beekman, Maryana Handula, Corrina de Ridder, and Debra Stuurman. "O-76 - Preclinical Evaluation of EPSMA-DM1: A PSMA-targeting Theranostic Small Molecule Drug Conjugate." Nuclear Medicine and Biology 126-127, no. Supplement (2023). https://doi.org/10.1016/j.nucmedbio.2023.108472.
MLA (8th ed.) CitationSeimbille, Yann, et al. "O-76 - Preclinical Evaluation of EPSMA-DM1: A PSMA-targeting Theranostic Small Molecule Drug Conjugate." Nuclear Medicine and Biology, vol. 126-127, no. Supplement, 2023, https://doi.org/10.1016/j.nucmedbio.2023.108472.
Visit our Citation Styles guide for help on properly citing sources.